Standout Papers

The major genetic defect responsible for the polymorphism of S-mephenytoin met... 1988 2026 2000 2013 773
  1. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. (1994)
    G. Wilkinson, Joyce Blaisdell et al. Journal of Biological Chemistry
  2. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. (1994)
    Sara Moráis, G. Wilkinson et al. Molecular Pharmacology
  3. The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology (2006)
    Urs Meyer, Myriel Nyffeler et al. Journal of Neuroscience
  4. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism (1988)
    Frank J. Gonzalez, Shioko Kimura et al. Nature
  5. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. (1989)
    Thomas Kronbach, Frank J. Gonzalez et al. Molecular Pharmacology
  6. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs (1988)
    Thomas Kronbach, Volker Fischer et al. Clinical Pharmacology & Therapeutics
  7. Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver (1989)
    Toshifumi Aoyama, Saki Yamano et al. Journal of Biological Chemistry
  8. PARENCHYMAL CELLS FROM ADULT RAT LIVER IN NONPROLIFERATING MONOLAYER CULTURE (1973)
    D. Montgomery Bissell, Lydia Hammaker et al. The Journal of Cell Biology

Immediate Impact

17 by Nobel laureates 23 from Science/Nature 63 standout
Sub-graph 1 of 18

Citing Papers

Infant microbes and metabolites point to childhood neurodevelopmental disorders
2024 Standout
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 Standout

Works of Urs Meyer being referenced

Amylin at the interface between metabolic and neurodegenerative disorders
2015
The Neurodevelopmental Impact of Prenatal Infections at Different Times of Pregnancy: The Earlier the Worse?
2007

Author Peers

Author Last Decade Papers Cites
Urs Meyer 8836 10107 5500 5762 371 30.9k
Julius Axelrod 12595 2407 835 1038 345 37.1k
Osamu Hayaishi 13532 1297 2649 3998 529 30.3k
Salvatore Cuzzocrea 13733 2105 1102 3663 914 42.3k
Richard M. Weinshilboum 8559 4926 802 3203 403 23.5k
Toshitaka Nabeshima 9173 732 2923 738 776 24.5k
Julio Licínio 5232 800 4589 527 309 20.6k
Mark A. Smith 23383 492 3854 2136 721 60.6k
Ahmad Reza Dehpour 4255 1075 1221 987 858 16.3k
Edward M. Sellers 4370 3945 342 1961 417 26.9k
Jon D. Levine 8986 1587 234 3206 579 35.6k

All Works

Loading papers...

Rankless by CCL
2026